<scp>NSE</scp> and <scp>ProGRP</scp> Are Promising Markers for Diagnosis, Efficacy Evaluation, Follow‐Up Monitoring, and Prognosis of Small Cell Esophageal Carcinoma
ProGRP and NSE have significant value in the diagnosis and differential diagnosis of SCEC, and are also associated with the clinical stage and prognosis of SCEC patients, as well as are effective indicators for evaluating therapeutic efficacy and disease recurrence.
Authors
- Jianjiao Ni (ORCID: https://orcid.org/0000-0003-3113-2586)
- D. Liu (ORCID: https://orcid.org/0000-0002-9981-9969)
- Suhong Xie (ORCID: https://orcid.org/0000-0003-1044-9373)
- Junhua Zhang (ORCID: https://orcid.org/0000-0002-8936-3822)
- Dan Wu (ORCID: https://orcid.org/0000-0002-5190-1277)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Eye & ENT Hospital of Fudan University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70026
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35